De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors

por Li, Jing-Wen, Cao, Shu-Hui, Xu, Jian-Lin, Zhong, Hua
Publicado 2019

A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab

por Nie, Wei, Qian, Jie, Xu, Mi-Die, Gu, Kai, Qian, Fang-Fei, Hu, Min-Juan, Lu, Jun, Gan, Lu, Zhang, Xue-Yan, Cao, Shu-Hui, Li, Jing-Wen, Wang, Yue, Zhang, Bo, Wang, Shu-Yuan, Hu, Fang, Li, Chang-Hui, Zhong, Hua, Han, Bao-Hui
Publicado 2020

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

por Nie, Wei, Gan, Lu, Wang, Xin, Gu, Kai, Qian, Fang-Fei, Hu, Min-Juan, Zhang, Ding, Chen, Shi-Qing, Lu, Jun, Cao, Shu-Hui, Li, Jing-Wen, Wang, Yue, Zhang, Bo, Wang, Shu-Yuan, Li, Chang-Hui, Yang, Ping, Xu, Mi–Die, Zhang, Xue-Yan, Zhong, Hua, Han, Bao-Hui
Publicado 2021